BioAge Labs Inc

BIOANASDAQ · USD
8.06USD0.00 (-0.38%)
5310

BioAge Labs Inc (BIOA) Covered Calls

As of September 18, 2026, BIOA has 9 covered call opportunities in the coming three months. Return ranges from 29.7 to 191.0% until expiration. Annualized return ranges from 29.6 to 749.5%. The nearest expiration is December 18, 2026. Maximum potential profit is $1,480.

Read more

Running BIOA covered calls helps you generate consistent income from BioAge Labs Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on BioAge Labs Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best BIOA covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if BIOA stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling BIOA covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given BioAge Labs Inc covered call is worth writing.

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets allows users to identify targets based on insights into molecular changes that drive aging. Its product includes azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It also develops BGE-100, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation.

The company was incorporated in 2015 and is based in Richmond, California.

Income-focused investors, long-term BIOA holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling BIOA covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best BioAge Labs Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryDrug Manufacturers - Specialty & Generic
  • SectorHealthcare
  • IV percentile37.70% Neutral
  • Market cap (M$)370
  • 52 weeks high-68.95%
  • 52 weeks low65.16%
  • Analyst recommendationStrong Buy
    1.44
  • Target price$35.62
    341.94% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-05
  • P/E
  • Future P/E
  • EPS (ttm)-2.39
  • EPS growth next 5 years-4.63%

As of September 18, 2026

2026-12-189322.50190.320.051.701480.00190.97749.50-0.65+0.2841.65
2027-01-1512112.5061.290.503.70525.0067.74204.35-6.45+0.5463.20
2027-04-1621215.0093.550.104.90735.0094.84163.28-1.29+0.5604.80
2026-12-189310.0029.030.604.70285.0036.77144.33-7.74+0.62754.10
2027-01-1512110.0029.031.001.50325.0041.94126.50-12.90+0.471,1310.50
2027-04-1621212.5061.290.104.90485.0062.58107.74-1.29+0.5814.80
2027-09-1736612.5061.291.005.00575.0074.1973.99-12.90+0.6304.00
2027-04-1621210.0029.030.104.90235.0030.3252.21-1.29+0.6104.80
2027-09-1736610.0029.030.055.00230.0029.6829.60-0.65+0.6204.95

As of September 18, 2026

Sell covered calls with the data behind you

Find the best BIOA covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial